Special Reports The 10 most-anticipated drug launches of 2020

Special Reports The 10 most-anticipated drug launches of 2020

Roche SMA therapy granted speedy FDA review; decision by May 2020

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!  Dive Brief: The Food and Drug Administration will give Roche's experimental therapy for spinal muscular atrophy a speedy review and will decide on approval within six months, the Swiss pharma​ said Monday. If approved, Roche's risdiplam would be the third SMA therapy … Συνεχίστε να διαβάζετε Roche SMA therapy granted speedy FDA review; decision by May 2020.

Amid Zolgensma crisis, Novartis gets a gene therapy boost as NICE embraces Luxturna

Amid Zolgensma crisis, Novartis gets a gene therapy boost as NICE embraces Luxturna

Can Gene Therapy Become The Cure For Blindness?

  Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    With the first gene therapy for blindness in the market, the door has been opened for a new wave of gene therapy treatments with the potential to cure genetic blindness.  In December 2017, the FDA approved Luxturna, the first … Συνεχίστε να διαβάζετε Can Gene Therapy Become The Cure For Blindness?.

The top 10 drug launches of 2019

The top 10 drug launches of 2019